Overweight & Obesity

Better obesity risk prediction with hip and waist measures

(HealthDay)—Inclusion of both waist and hip circumference as separate anthropometric measurements may improve risk prediction for obesity-related mortality and morbidity, according to research published online Oct. 17 in ...

Diseases, Conditions, Syndromes

Guideline implementation may impact VTE quality of care

The quality of care of patients hospitalized with venous thromboembolism (VTE) significantly improved between 2005 and 2009, and researchers suggest these improvements may be due to the implementation of VTE treatment guidelines.

Oncology & Cancer

Unsuspected PE seldom linked to death in cancer patients

(HealthDay)—Unsuspected pulmonary embolism (UPE) is not associated with an increased risk of death in cancer patients when compared to patients without pulmonary embolism (PE), according to research published in the October ...

Medications

Proof of added benefit of apixaban in hip replacement

The clot-inhibiting drug apixaban (trade name: Eliquis) was approved in May 2011 for the prevention of thrombosis (blood clots) after operations to replace a hip or knee joint. In an early benefit assessment pursuant to the ...

Diseases, Conditions, Syndromes

Patients underestimate risk of deep vein thrombosis, say researchers

(Medical Xpress)—Many people going into hospital have concerns about contracting the hospital acquired infection MRSA, yet the risk of acquiring - and dying from – hospital acquired venous thromboembolism (VTE) is much ...

Cardiology

Omission of aspirin from antiplatelet regimen: The WOEST study

Lifelong anticoagulation is necessary for the prevention of stroke in patients with rhythm disturbances and with mechanical valves. Patients who have a coronary stent implanted also need the antiplatelet drugs aspirin and ...

page 21 from 25